Therefore, to investigate the correlation between each NFYA variant and PCK1 in 297 liver cancers using RNA-seq data from TCGA, we classified by the logFC of VIM/CDH1 into two groups: those predominantly expressing NFYAv1 (1 < logFC) and those predominantly expressing NFYAv2 (logFC < −1). This evidence concerns the gene VIM and liver cancer.